Open enrollment for Affordable Care Act plans available through HealthCare.gov is from November 1 to January 15. Keep your ARC care team by choosing from insurance plans we accept: Aetna, Ambetter, Blue Cross, Blue Advantage, MyBlue, Moda, Sendero, and UnitedHealthcare Exchange Plan.
All insurance plans accepted by ARC, including government plans, are listed online at ARCInsuranceInfo.com.
If you have received a letter from UnitedHealthcare (UHC) stating that any of the providers listed below are out-of-network, please be informed that refers to their former practice. The following physicians and APC remain in-network at ARC, and you may continue seeing them without any changes to your coverage:
Ongoing clinical studies are studies that are currently in progress and no longer enrolling new participants. Visit our Enrolling Studies page for a full list of clinical studies you may be eligible to participate in.
A phase III trial to assess the efficacy, safety, and tolerability of zibotentan combined with dapagliflozin, compared to dapagliflozin alone, in participants with chronic kidney disease and high proteinuria.